These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20946237)

  • 1. No effect of systemic isocapnic hypoxia on α-adrenergic vasoconstrictor responsiveness in human skin.
    Simmons GH; Fieger SM; Wong BJ; Minson CT; Halliwill JR
    Acta Physiol (Oxf); 2011 Mar; 201(3):339-47. PubMed ID: 20946237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous vascular and core temperature responses to sustained cold exposure in hypoxia.
    Simmons GH; Barrett-O'Keefe Z; Minson CT; Halliwill JR
    Exp Physiol; 2011 Oct; 96(10):1062-71. PubMed ID: 21705404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradermal administration of ATP does not mitigate tyramine-stimulated vasoconstriction in human skin.
    Wingo JE; Brothers RM; Del Coso J; Crandall CG
    Am J Physiol Regul Integr Comp Physiol; 2010 May; 298(5):R1417-20. PubMed ID: 20237299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral vitamin C enhances the adrenergic vasoconstrictor response to local cooling in human skin.
    Yamazaki F
    J Appl Physiol (1985); 2012 May; 112(10):1689-97. PubMed ID: 22383508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans.
    Stephens DP; Saad AR; Bennett LA; Kosiba WA; Johnson JM
    Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1404-9. PubMed ID: 15165988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of elevated local temperature on cutaneous vasoconstrictor responsiveness in humans.
    Wingo JE; Low DA; Keller DM; Brothers RM; Shibasaki M; Crandall CG
    J Appl Physiol (1985); 2009 Feb; 106(2):571-5. PubMed ID: 19056996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a functional vasoconstrictor role for ATP in the human cutaneous microvasculature.
    Lang JA; Krajek AC; Smaller KA
    Exp Physiol; 2017 Jun; 102(6):684-693. PubMed ID: 28295755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of systemic hypoxia to blunt alpha-adrenergic vasoconstriction in the human forearm.
    Dinenno FA; Joyner MJ; Halliwill JR
    J Physiol; 2003 Jun; 549(Pt 3):985-94. PubMed ID: 12730336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic cutaneous vasodilation is sustained during brief cold stress and is not affected by changes in CO2.
    Simmons GH; Fieger SM; Minson CT; Halliwill JR
    J Appl Physiol (1985); 2010 Apr; 108(4):788-92. PubMed ID: 20167671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin.
    Thompson-Torgerson CS; Holowatz LA; Flavahan NA; Kenney WL
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1700-5. PubMed ID: 17172270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral sapropterin augments reflex vasoconstriction in aged human skin through noradrenergic mechanisms.
    Stanhewicz AE; Alexander LM; Kenney WL
    J Appl Physiol (1985); 2013 Oct; 115(7):1025-31. PubMed ID: 23869061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized tyrosine or tetrahydrobiopterin supplementation corrects the age-related decline in cutaneous vasoconstriction.
    Lang JA; Holowatz LA; Kenney WL
    J Physiol; 2010 Apr; 588(Pt 8):1361-8. PubMed ID: 20176627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic hypoxia and vasoconstrictor responsiveness in exercising human muscle.
    Wilkins BW; Schrage WG; Liu Z; Hancock KC; Joyner MJ
    J Appl Physiol (1985); 2006 Nov; 101(5):1343-50. PubMed ID: 16809628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of endothelial nitric oxide synthase, noradrenaline, and neuropeptide Y to local warming-induced cutaneous vasodilatation in men.
    Hodges GJ; Sparks PA
    Microvasc Res; 2013 Nov; 90():128-34. PubMed ID: 24012636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pronounced and sustained cutaneous vasoconstriction during and following cyrotherapy treatment: Role of neurotransmitters released from sympathetic nerves.
    Christmas KM; Patik JC; Khoshnevis S; Diller KR; Brothers RM
    Microvasc Res; 2018 Jan; 115():52-57. PubMed ID: 28842183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local tetrahydrobiopterin administration augments cutaneous vasoconstriction in aged humans.
    Lang JA; Holowatz LA; Kenney WL
    J Physiol; 2009 Aug; 587(Pt 15):3967-74. PubMed ID: 19491246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of nitric oxide in the cutaneous vasoconstrictor response to local cooling in humans.
    Hodges GJ; Zhao K; Kosiba WA; Johnson JM
    J Physiol; 2006 Aug; 574(Pt 3):849-57. PubMed ID: 16728451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenaline and neuropeptide Y contribute to initial, but not sustained, vasodilatation in response to local skin warming in humans.
    Hodges GJ; Sparks PA
    Exp Physiol; 2014 Feb; 99(2):381-92. PubMed ID: 24213859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of baseline in the cutaneous vasoconstrictor responses during combined local and whole body cooling in humans.
    Hodges GJ; Kosiba WA; Zhao K; Alvarez GE; Johnson JM
    Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H3187-92. PubMed ID: 17906104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonnoradrenergic mechanism of reflex cutaneous vasoconstriction in men.
    Stephens DP; Aoki K; Kosiba WA; Johnson JM
    Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1496-504. PubMed ID: 11247759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.